MedTrace Logo

Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer

NCT02307539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-06-03

No results posted yet for this study

Summary

This pilot clinical trial studies a palliative care program in improving the quality of life of patients with newly diagnosed pancreatic cancer. Palliative care is care given to patients who have a serious or life-threatening disease, and focuses on managing disease symptoms, side effects of treatment or the disease, and improving patient quality of life. Studying a palliative care program used for other types of cancer may help doctors learn whether it can improve the quality of life of patients with pancreatic cancer.

Conditions

  • Stage IIA Pancreatic Cancer
  • Stage IIB Pancreatic Cancer
  • Stage III Pancreatic Cancer
  • Stage IV Pancreatic Cancer

Interventions

PROCEDURE

Psychosocial Assessment and Care

Undergo PCPI

OTHER

Palliative Therapy

Undergo PCPI

OTHER

Quality-of-Life Assessment

Undergo QOL assessment

OTHER

Questionnaire Administration

Undergo questionnaire administration

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Virginia Sun · City of Hope Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02307539 on ClinicalTrials.gov